Alteogen Inc.
196170
Clasificación en acciones
#1836
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters,... ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial; and Biogen Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Precio por acción
$165.61
Capitalización bursátil
$11.53B
Cambio (1 día)
4.13%
Cambio (1 año)
-46.48%
País
KR
Comercio Alteogen Inc. (196170)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Alteogen Inc. (196170)
La acción Alteogen Inc. (símbolo: 196170) tuvo un total de 5 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 05, 2026.
Una acción 196170 comprada antes de Dec 07, 2017 equivaldría hoy a 1.2037037037037 acciones 196170.
El desdoblamiento más reciente ocurrió el Aug 05, 2026.
Una acción 196170 comprada antes de Dec 07, 2017 equivaldría hoy a 1.2037037037037 acciones 196170.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| 2026-08-05 | 13:10 | x1.3 | x1.2037037037037 |
| 2022-10-25 | 6:5 | x1.2 | x0.92592592592593 |
| 2021-03-24 | 5:4 | x1.25 | x0.77160493827161 |
| 2020-07-23 | 10:9 | x1.1111111111111 | x0.61728395061728 |
| 2017-12-07 | 5:9 | x0.55555555555556 | x0.55555555555556 |
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
